NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

AIMS: End-stage renal disease (ESRD) treated by chronic hemodialysis (HD) is associated with poor cardiovascular (CV) outcomes, with no available evidence-based therapeutics. A multiplexed proteomic approach may identify new pathophysiological pathways associated with CV outcomes, potentially action...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossignol, P, Duarte, K, Bresso, E, A, Åsberg, Devignes, M D, Eriksson, N, Girerd, N, Glerup, R, Jardine, A G, Holdaas, H, Lamiral, Z, Leroy, C, Massy, Z, März, W, Krämer, B, Wu, P H, Schmieder, R, Soveri, I, Christensen, J H, Svensson, M, Zannad, F, Fellström, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797490/
https://www.ncbi.nlm.nih.gov/pubmed/36600882
http://dx.doi.org/10.1093/ehjopen/oeac069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797490/
https://www.ncbi.nlm.nih.gov/pubmed/36600882
http://dx.doi.org/10.1093/ehjopen/oeac069

Ejemplares similares